Mustang Bio, Inc. (MBIO)
Last updated: 2026-10-20 18:47:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Mustang Bio, Inc. (MBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.38, with a market capitalization of $2.85M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.37 to $1.69. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.85M | |
$0.37 | |
$10,012.50 | |
$0.37 | |
$0.37 | |
7.85K | |
32.28K | |
-- | |
$1.69 | |
$0.37 | |
-- | |
-- |
Mustang Bio, Inc. (MBIO) Stock Price Today
Mustang Bio, Inc. (MBIO) is currently trading at $0.38 as of 2026-10-20 18:45:00, up 2.68% ($0.01) from the previous close of $0.37
During today's regular trading session, MBIO has traded between $0.37 and $10,012.50, with a trading volume of 7.85K shares. The current price is near the lower end of today's range.
Mustang Bio, Inc. (MBIO) 7-Day Stock Price Change
Over the past seven days, Mustang Bio, Inc. (MBIO) moved from $0.40 to $0.38, representing a decline of 4.27% ($0.02).
The stock traded between $0.37 and $0.44 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 59.49 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
MBIO 52-Week Price Position
Position in Range: 1.0%
MBIO is currently trading at $0.38, placing it 1.0% of the way from its 52-week low of $0.37 to its 52-week high of $1.69. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Mustang Bio, Inc. (MBIO)?
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Mustang Bio, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 4 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Mustang Bio, Inc. (MBIO) Stock on MEXC
Eligible investors can buy real shares of Mustang Bio, Inc. (MBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Mustang Bio, Inc. (MBIO) stock price today?
2.Is MBIO stock going up or down today?
3.What is MBIO pre-market price?
4.What is MBIO after-hours price?
5.Is MBIO stock trading now?
6.Where does MBIO sit relative to its 52-week high and low?
7.What sector is Mustang Bio, Inc. in?
8.What is Mustang Bio, Inc.'s market capitalization and where is it listed?
9.How is MBIO valued in terms of P/E ratio and EPS?
10.Does Mustang Bio, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
MBIO Stock Calculator
Estimate the value between MBIO shares and USD.
MBIO Shares to USD
1.00 MBIO shares = 0.383 USD
Calculations are estimates based on the latest available price and are for reference only.


